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ABSTRACT
Background and Objectives: Laparoscopic procedures
are becoming increasingly popular, even in the severely ill
patient. We present a case of a cardiac transplant candidate
with an ejection fraction of less than 15% who underwent a
laparoscopic cholecystectomy. This is the first case in which
intraoperative hemodynamic measurements were recorded
in a patient with cardiopulmonary disease this severe.
Methods: The patient underwent the procedure while
measurements were made at crucial intervals (baseline, with
incremental insufflation, reverse Trendelenberg, at desuffla-
tion) using a pulmonary artery catheter, transesophageal
echocardiography with fractional area measurements, radial
arterial line, as well as standard monitoring.
Results: This patient showed hemodynamic changes con-
sistent with a person without severe heart disease. There
was a rise in mean arterial and systemic vascular resistance
with insufflation to 10 mm Hg, which was further exagger-
ated by reverse Trendelenberg.
Heart rate and pulmonary artery wedge pressure increased
slightly. The cardiac output and fractional area change
declined minimally.
Conclusions: We conclude that if a patient with conges-
tive heart failure is medically optimized, and intra-abdomi-
nal pressures and surgical times are minimized, laparoscop-
ic cholecystectomy may be performed with minimal risk to
the patient.
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INTRODUCTION
Increasingly, laparoscopic procedures are being utilized to
decrease postoperative pain and length of hospital stay.
The one group in which laparoscopy may have adverse
effects, that outweigh the potential benefits, is the patient
with severe cardiopulmonary disease. There has not been
a case reported of a laparoscopic procedure with hemody-
namic measurements on a patient with an ejection fraction
of less than 20%. We present a case of a patient with end-
stage cardiac disease with an ejection fraction estimated at
less than 15% who underwent laparoscopic cholecystecto-
my prior to becoming eligible for cardiac transplant.
CASE REPORT
A 59 year old woman presented with end-stage idiopathic
cardiomyopathy. The patient had asymptomatic cholelithi-
asis and was to undergo a laparoscopic vs. open cholecys-
tectomy prior to becoming eligible for cardiac transplant.
An echocardiogram two weeks prior to admission revealed
a normal sinus rhythm, global hypokinesis with an ejection
fraction of less than 15%; valvular abnormalities included
mild mitral and tricuspid regurgitation. A right and left car-
diac catheterization one week prior to this admission con-
firmed the above, and revealed pulmonary hypertension
with pulmonary artery pressures of 72/35. The mean pul-
monary artery pressure improved to 26 mm Hg with sodi-
um nitroprusside.
Pertinent medications included metropolol 6.25 mg po BID,
digoxin 0.125 mg po q d, enalapril 20 mg po BID,
furosemide 40 mg po q d, and coumadin 4 mg po q d.
Physical exam was without evidence of congestive heart
failure. Laboratory evaluation was within normal limits.
Upon arrival in the operating room, the patient was con-
nected to standard monitoring (i.e., 5-lead EKG, pulse
oximetry, arterial blood pressure, capnography, and body
temperature). Prior to induction, a radial arterial line and
oximetric pulmonary artery catheter were placed through
the right internal jugular vein. Induction was accomplished
with Etomidate 0.3 mg/kg, fentanyl 10 meg/kg, and
succhinylcholine 1.0 mg/kg. After entubation, a Hewlett-
Packard biplanar transesophageal echocardiography probe
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Figure 1. Pulmonary Artery Wedge Pressure (PAWP),
Fractional Area Change (FAC) by transesophageal
echo., Systemic Vascular Resistance (SVR), Mean
Arterial Pressure (MAP), Cardiac Output (CO), Heart
Rate (HR) recorded at 5 minutes after an intra-
abdominal pressure of 5 mm Hg, 10 mm Hg, assum-
ing 10 degrees reverse Trendelenberg (RT), and on
return to supine and desufflation of the abdomen.
(Model # 21362A) at 5.0 MHz frequency was positioned to
obtain a transgastric short axis view of the midpapillary
level of the left ventricle.
Anesthesia was maintained with isoflurane at 0.35-0.45%,
nitrous oxide 50% in oxygen 50%. Muscle relaxation was
accomplished with vecuronium maintaining 1 of 4 twitches
on a train-of-four. Ventilation was controlled with the pH
ranging between 7.35-7.40 and pCO2 40-48 mm Hg. The
case lasted 42 minutes. Blood loss was minimal, and the
patient received a total of 10ml/kg of Lactated Ringer's
intravenously.
Measurements were taken pre-induction, immediately post-
induction, five minutes after pneumoperitoneal insufflation
to 5 mm Hg, five minutes after insufflation to 10 mm Hg,
five minutes after 10 degrees of reverse Trendelenburg
position, and five minutes after return to the supine posi-
tion and desufflation.
Parameters measured included heart rate, blood pressure,
pulmonary artery pressures, cardiac output, pulmonary
artery occlusion pressure, and central venous pressure.
With each change in table position, pressure transducer
height was adjusted to maintain a constant phlebostatic axis
with respect to the right atrium. Videotaped recordings of
the intraoperative echocardiogram were used to evaluate
for wall motion abnormalities and to calculate left ventric-
ular fractional area change postoperatively. Analysis was
performed via manual planimetry by a skilled observer
(DCK) blinded to intraoperative events. End-diastolic
(EDA) and end-systolic areas (ESA) were planimetered on
two consecutive cardiac cycles and averaged using the
leading edge of the left ventricular endocardial border.
EDA was determined by the greatest cross-sectional area
obtained at the peak of the electrocardiogram R wave. The
ESA was determined by the smallest left ventricular area
obtained. Percent ejection fraction area (%EFa) was deter-
mined from the formula %EFa = (EDA-ESA/EDA) X 100.
DISCUSSION
Laparoscopic cholecystectomy is becoming an increasingly
popular alternative to open cholecystectomy. The laparo-
scopic procedure combines the benefit of completely
removing the gallbladder with the advantages of a shorter
hospital stay, less pain, and less chance of postoperative
ileus compared to the open cholecystectomy.
1 Pulmonary
function is better preserved postoperatively, resulting in
better oxygenation and ventilation.
These advantages should provide theoretical benefits for
patients with heart disease requiring cholecystectomy;
however, the use of peritoneal insufflation, CO2 as the
insufflating gas, and reverse Trendelenburg position neces-
sary for a laparoscopic cholecystectomy have been shown
to cause significant alterations in hemodynamic parameters.
Some of these changes might discourage the use of laparo-
90 JSLS (1998)2:89-92scopic cholecystectomy in high-risk cardiac patients, espe-
cially those with very low ejection fractions.
Laparoscopy has been well studied, especially in the
healthy gynecologic patient. The three variables that effect
the patient's hemodynamic parameters are insufflation, the
use of CO2 as the insufflant, and patient position.
The extent of the cardiovascular changes associated with
creation of pneumoperitoneum depends on the intra-
abdominal pressure (IAP) attained. With our patient, the
IAP was limited to 10 mm Hg. Because of her thin body
habitus, this limitation was not difficult to accomplish, yet
still provided adequate visualization for surgery. In healthy
patients undergoing laparoscopic cholecystectomy, the
usual IAP is 15 mm H2O. At this IAP the filling pressures
and mean arterial pressure (MAP) may increase, but cardiac
output (CO) typically remains unchanged.
2,
3 In patients
with severe heart disease, however, changes in hemody-
namic parameters have varied between investigators.
Iwase et al.,
4 utilizing IAPs of 12 mm Hg, have described
hemodynamic changes similar to our patient. However,
Safran et al.,
5 using 15 mm Hg IAPs, noted that several
high-risk cardiac patients experienced decreases in CO and
SvO2. They felt that these patients were relatively volume
depleted preinsufflation, then worsened with a further
decrease in preload when insufflation was applied. Portera
et al.
6 similarly describe a significant fall in cardiac index
(CI) and stroke volume (SV) despite preoperative opti-
mization of preload and cardiac output using fluid boluses.
Neither Safran nor Iwase reported any intraoperative car-
diac complications or any increase in postoperative mor-
bidity or mortality. Portera, on the other hand, reported
two cases of postoperative congestive heart failure. He
observed a progressive decrease in CI, SV, and left ventric-
ular stroke work following desufflation in these patients;
but, he could not identify any obvious feature preopera-
tively, or at the time of insufflation, that might predict
which patients might be at risk.
The hemodynamic course of our patient was uneventful
(Figure 1). At 10 mm Hg, our patient had changes similar
to a healthy patient, documented by an increase in MAP
and pulmonary artery wedge pressure (PAWP); end dias-
tolic volume (estimated as End-Diastolic Area - EDA) and
CO remained unchanged. Systemic vascular resistance
(SVR) also increased with insufflation. With our patient's
complicated preoperative course, consisting of two admis-
sions within four weeks for CHF, one would have expect-
ed her to be relatively volume depleted and as such
respond with an increase in BP and HR. Prior to desuffla-
tion, the most unusual finding was the decrease in echocar-
diographic fractional area change (FAC) to 12%; this finding
mirrors (and is most probably explained by) a peak
increase in SVR. Following desufflation, all hemodynamic
parameters corrected in an appropriate fashion: increased
stroke volume secondary to improved preload, decreased
SVR (reduced afterload) with subsequent increase in car-
diac output, and a decrease in heart rate.
The use of CO2 as the insufflant did not place our patient
at risk. Hypercarbia over 50 mm Hg in healthy patients
causes myocardial depression and is a direct vasodilator; as
a result, there is a decrease in CO, SVR, and pH.
7-1
1
Hypercarbia at levels less than 50 mm Hg has been shown
to produce minimal hemodynamic effects.
7-
9 In patients
with ischemic heart disease, PaCO2 levels of 55-65 mm Hg
resulted in an increase in systolic BP, HR, and CO.
8 There
was also a two to threefold increase in plasma cate-
cholamine concentrations which suggests hypercarbia stim-
ulates the sympathetic nervous system in this group of
patients.
8 We had no difficulty maintaining a PaCO2 below
50 mm Hg in our patient; her lean body habitus was a con-
tributing factor in our ability to maintain adequate ventila-
tion. It is unclear whether her upward trend in HR, MAP,
and SVR (suggestive of an increase in sympathetic stimula-
tion) was related to the mild hypercarbia present, or to a
drop in preload (see EDV, Figure 1).
Theoretically, the change to reverse Trendelenburg should
cause cardiovascular compromise in the form of decreased
venous return (VR) and CO. This decline may be offset by
a decrease in afterload leading to an insignificant change in
CO in otherwise healthy patients.
The study done by Safran looking at laparoscopic chole-
cystectomy in patients with severe cardiac disease utilized
an IAP of 15 mm Hg and maintained normal end-tidal CO2
(ETCO2).
5 The reverse Trendelenburg position was used in
most of the 15 ASA Physical class III and IV patients evalu-
ated. Unfortunately, hemodynamic parameters were not
measured after the establishment of pneumoperitoneum
independently of assuming reverse Trendelenburg. Also,
there was no mention as to the degree of reverse
Trendelenburg attained. A significant increase in MAP and
SVR accompanied by a decrease in CO was found. These
changes were thought to be due to aggressive treatment of
congestive heart failure preoperatively, thus leading to a
volume depleted patient with little intravascular volume
reserve. In our patient, the only significant finding on
assuming 10 degrees of reverse Trendelenburg position
was an increase in the SvO2 from 83% to 90%. This was
most likely due to improved respiratory mechanics. This
elevation in SvO2 came in conjunction with a decline in
ETCO2 from 38 mm Hg to 30 mm Hg, adding further cre-
dence to the improvement in pulmonary function as the
probable mechanism.
We evaluated transesophageal echocardiography (TEE) as
an aid to monitoring this patient during laparoscopic chole-
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cystectomy. Following the establishment of pneumoperi-
toneum and assumption of the reverse Trendelenburg posi-
tion, the FAC via TEE was assessed as an indirect measure
of ejection fraction (EF). No significant changes or trends
could be identified utilizing this technique, perhaps due to
subtle changes in wall thickening and short axis diameters
in a patient with a low EF. Portera et al.
6 were also unable
to find benefit of TEE use as an intraoperative monitor in
laparoscopic patients with cardiac disease.
We conclude from this case that laparoscopic cholecystec-
tomy can be performed safely in patients with severe car-
diac disease and ejection fractions less than 20%. Under
these circumstances it is imperative that appropriate moni-
toring be utilized, and IAP, reverse Trendelenburg and sur-
gical time minimized.
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